Arqit Quantum lacks a true consensus forecast. The only current numeric target on record is H.C. Wainwright’s $60 objective, which was raised from $52 in October 2025 and kept in December 2025. That call rests on improving fundamentals and growth in the post-quantum space. Morgan Stanley and UBS added Overweight and Buy coverage in October 2026, yet neither has released a verifiable price target, so the $60 level remains a single-analyst view rather than an averaged outlook. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
At the verified close of roughly $12.35, the gap to $60 is about 386 percent. The stock sits below both its 50-day and 200-day moving averages after giving back most of an October bounce. Trailing twelve-month revenue is around $1.1 million while the net loss approaches $49 million, so any sustained climb would need more than sentiment—it would require clear commercial progress and narrowing losses.
The case for upside rests on timing. Regulators and enterprises are accelerating migration to post-quantum cryptography, with NIST standards helping set the pace. Arqit’s tools cover encryption-risk assessment and software-based solutions aligned with those standards. An October 2026 investment in Sirius Computer targets quantum-safe communications for defense and government clients, and the company holds roughly $26.7 million in net cash for runway.
Challenges remain sizable. Revenue of about $1.1 million against nearly $49 million in losses produces a very high price-to-sales multiple with no positive earnings anchor. Past share issuance and a 1-for-25 reverse split in 2024, along with repeated insider sales including by the CEO, have pressured sentiment. A beta near 3.0 and notable short interest leave the shares sensitive to risk appetite and broader moves in speculative quantum names.
The shares remain in a downtrend, hovering near support at the 52-week low of approximately $11.52. Overhead resistance sits at the 50-day average near $18.30 and the 200-day average near $17.60. The prior 52-week high around $31.75 is a more distant hurdle. A durable path toward $60 would first require reclaiming those averages and then clearing the earlier high, steps that currently lack a confirmed catalyst.
Analyst targets generally look out about 12 months. Investors should track the next earnings release expected in early December 2026, any numeric targets from the recent Morgan Stanley and UBS coverage, new government or enterprise contract wins, the pace of insider activity, and interest-rate trends that often sway high-beta technology names. From what I see, contract flow and cash-burn trends will matter most.
Tickeron’s AI Daily Buy/Sell Signals apply artificial intelligence to scan thousands of stocks and ETFs, producing Buy, Sell, or Hold signals based on technical shifts and market conditions. For a volatile name like ARQQ with limited coverage, these signals can help identify momentum changes and manage risk without screening the entire market manually. I find them useful for spotting short-term shifts in names that move quickly on limited news.
Whether Arqit Quantum can reach $60 depends on one analyst’s bullish call rather than a wide consensus, and it would require a roughly 386 percent advance from current levels. The bull thesis is credible yet early-stage: rising post-quantum demand and government interest could support a higher valuation over time. The bear case is equally tangible—thin revenue, ongoing losses, dilution, insider sales, and a high-beta downtrend make the climb steep. Reaching the target would need a genuine shift in commercial traction, not just better sentiment. I’m watching contract announcements and cash usage closely before assuming any outcome.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking
ARQQ saw its Momentum Indicator move below the 0 level on November 20, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 74 similar instances where the indicator turned negative. In 68 of the 74 cases, the stock moved further down in the following days. The odds of a decline are at 90%.
The Moving Average Convergence Divergence Histogram (MACD) for ARQQ turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 48 similar instances when the indicator turned negative. In 40 of the 48 cases the stock turned lower in the days that followed. This puts the odds of success at 83%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where ARQQ declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for ARQQ entered a downward trend on November 13, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The RSI Indicator entered the oversold zone -- be on the watch for ARQQ's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.
Following a +2.10% 3-day Advance, the price is estimated to grow further. Considering data from situations where ARQQ advanced for three days, in 206 of 242 cases, the price rose further within the following month. The odds of a continued upward trend are 85%.
ARQQ may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Tickeron PE Growth Rating for this company is 38 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 85 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.744) is normal, around the industry mean (16.188). P/E Ratio (-5.267) is within average values for comparable stocks, (45.064). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.427) among similar stocks. P/S Ratio (277.778) is also within normal values, averaging (103.301).
The Tickeron Price Growth Rating for this company is 85 (best 1 - 100 worst), indicating slightly worse than average price growth. ARQQ’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ARQQ’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications